Finance

Beta
Lists
BIS:BKK
Bioscience Animal Health PCL
THB 2.06
0.00%
(0.00) 1D
Jun 4, 4:40:00 PM GMT+7  ·   THB
All symbols
SymbolPriceChange% Change
Generating top insights for BIS...
Open
THB 2.06
High
THB 2.10
Low
THB 2.00
Mkt. cap
646.84M
Avg. vol.
77.07K
Volume
543.30K
Dividend
5.83%
Quarterly dividend
THB 0.03
Ex-dividend date
Apr 29, 2026
P/E ratio
17.30
52-wk high
THB 3.12
52-wk low
THB 1.70
EPS
THB 0.12
Shares outstanding
314.00M
No. of employees
151
Open
THB 2.06
High
THB 2.10
Low
THB 2.00
Mkt. cap
646.84M
Avg. vol.
77.07K
Volume
543.30K
Dividend
5.83%
Quarterly dividend
THB 0.03
Ex-dividend date
Apr 29, 2026
P/E ratio
17.30
52-wk high
THB 3.12
52-wk low
THB 1.70
EPS
THB 0.12
Shares outstanding
314.00M
No. of employees
151
News stories
From sources across the web
About Bioscience Animal Health PCL
CEO-
Employees151
FoundedFeb 20, 2004
Headquarters-
SectorHealth care provider
Websitebis-group.com
Previous reportsAll values in THB
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in THB
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
547.44M
534.91M
597.56M
541.88M
Cost of goods sold
460.83M
468.18M
498.18M
450.07M
Cost of revenue
460.83M
468.18M
498.18M
450.07M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69.79M
61.47M
118.59M
62.72M
Operating expense
61.20M
52.34M
108.24M
67.54M
Total operating expenses
522.03M
520.52M
606.43M
517.61M
Operating income
25.41M
14.39M
-8.86M
24.27M
Other non operating income
-
-
-
-
EBT including unusual items
25.07M
14.14M
-8.89M
24.19M
EBT excluding unusual items
25.07M
14.14M
-8.89M
24.19M
Income tax expense
5.56M
2.91M
-1.37M
4.82M
Effective tax rate
22.16%
20.57%
15.38%
19.93%
Other operating expenses
-8.59M
-9.14M
-10.35M
4.82M
Net income
18.53M
9.63M
-8.30M
17.53M
Net profit margin
3.38%
1.80%
-1.39%
3.23%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-343.00K
-245.00K
-30.00K
-80.00K
Net interest expenses
-343.00K
-245.00K
-30.00K
-80.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
30.55M
19.47M
-4.92M
28.21M
Gain or loss from assets sale
-
-
-4.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer